Select Medical Q2 revenue +4.5% to $1.34B, EPS $0.32, reaffirms FY2025 outlook

SELECT MEDICAL HOLDINGS CORP

2025-Q2 EPS reported $0.76 revenue$2,692,751,000

Revenue $1,339.6M (+4.5% YoY); net income from continuing ops $57.9M (+53.8%).
Adjusted EBITDA $125.4M (+0.5% YoY); diluted EPS $0.32 vs $0.17 (+88.2%).
Rehab hospital revenue +17.2% to $313.8M; critical illness revenue -0.6% to $601.1M.
Reaffirms FY2025 revenue $5.3B-$5.5B, Adj EBITDA $510M-$530M, EPS $1.09-$1.19.
Declares $0.0625/share cash dividend (payable Aug 28); $1B buyback program ongoing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.